VivoSim Labs (VIVS) EBITDA Margin (2011 - 2026)
VivoSim Labs (VIVS) posted EBITDA Margin of -15105.56% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 7392.04 percentage points from -7713.51% a year earlier and down 7245.56 percentage points from the prior quarter.
VivoSim Labs (VIVS) EBITDA Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at VivoSim Labs was -9943.75%, down 1571.92 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -8604.58%, down 28.19 percentage points from FY2025.
- Annual EBITDA Margin shows a four-year change of -7848.78 percentage points (FY2022 to FY2026).
- In prior fiscal years, VivoSim Labs' EBITDA Margin was -8576.39% in FY2025 (+5007.10 pp), -13583.49% in FY2024 (-8870.51 pp), -4712.97% in FY2023 (-3957.17 pp) and -755.80% in FY2022.
- The fiscal Q1 2027 figure stands as the lowest quarterly EBITDA Margin since fiscal Q3 2024.
- On a year-over-year basis, EBITDA Margin increased in four of the last seven quarters, with an average year-over-year change of +8148.26 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was fiscal Q3 2025, with a gain of 58009.17 percentage points; the weakest was fiscal Q3 2024, with a drop of 69715.11 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior fiscal quarters was -7860.00% (Q4 2026), -10376.92% (Q3 2026) and -9200.00% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.64 Bn | 36.34 Bn | 1.44 Bn | 18.41% |
| 2 | Medpace Holdings | 17.77 Bn | 15.83 Bn | 201.64 Mn | 21.71% |
| 3 | Charles River Laboratories International | 15.06 Bn | 14.26 Bn | 363.37 Mn | 18.64% |
| 4 | Icon | 13.79 Bn | 10.91 Bn | 479.29 Mn | 11.15% |
| 5 | Fortrea Holdings | 2.21 Bn | 1.59 Bn | 139.20 Mn | 5.07% |
| 6 | Ginkgo Bioworks Holdings | 633.98 Mn | -128.10 Mn | 18.44 Mn | -229.38% |
| 7 | Evotec SE | 523.86 Mn | -1.09 Bn | - | - |
| 8 | Champions Oncology | 66.64 Mn | 41.72 Mn | 7.70 Mn | -0.62% |
| 9 | MindWalk Holdings | 60.76 Mn | 24.41 Mn | 1.61 Mn | -152.92% |
| 10 | VivoSim Labs | 922,669.26 | -16.80 Mn | - | -15,105.56% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,105.56% |
| Mar 31, 2026 | -7,860.00% |
| Dec 31, 2025 | -10,376.92% |
| Sep 30, 2025 | -9,200.00% |
| Jun 30, 2025 | -7,713.51% |
| Mar 31, 2025 | -6,064.71% |
| Dec 31, 2024 | -14,170.83% |
| Sep 30, 2024 | -8,466.67% |
| Jun 30, 2024 | -8,502.56% |
| Mar 31, 2024 | -10,431.03% |
| Dec 31, 2023 | -72,180.00% |
| Jun 30, 2023 | -5,504.00% |
| Mar 31, 2023 | -4,765.43% |
| Dec 31, 2022 | -2,464.89% |
| Sep 30, 2022 | -4,285.71% |
| Mar 31, 2022 | -124.47% |
| Dec 31, 2019 | -1,502.35% |
| Sep 30, 2019 | -540.89% |
| Jun 30, 2019 | -945.51% |
| Mar 31, 2019 | -1,030.29% |
VivoSim Labs EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VIVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VIVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VIVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();